Market research
HQ10.F ARCA biopharma, Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.9
Community
Investor discussion
1 comment
Sign in to join the HQ10.F discussion.
5 years, 5 months ago
ARCA biopharma, Inc is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
ARCA biopharma, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 318.0% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 159.3% to $-3M since the same quarter in the previous year.
Based on the above factors, ARCA biopharma, Inc gets an overall score of 1/5.